The Pfizer Covid-19 vaccine appears to offer 100% protection against the South African variant and most likely protects against the Brazilian variant, two new studies suggest.
Research published by Pfizer/BioNTech on Thursday offers the first in-human evidence of how the vaccine protects against the South African variant that has been worrying scientists.
The pharmaceutical giant said its findings show the vaccine is 100% effective in preventing Covid-19 cases in South Africa – where the South African variant is now common.
(PA Graphics)
Among 800 people in South Africa, nine cases of the South African variant of Covid were observed – all in the group not given the vaccine.
The Pfizer Covid-19 vaccine appears to offer 100% protection against the South African variant and most likely protects against the Brazilian variant, two new studies suggest.
Research published by Pfizer/BioNTech on Thursday offers the first in-human evidence of how the vaccine protects against the South African variant that has been worrying scientists.
The pharmaceutical giant said its findings show the vaccine is 100% effective in preventing Covid-19 cases in South Africa – where the South African variant is now common.
(PA Graphics)
Among 800 people in South Africa, nine cases of the South African variant of Covid were observed – all in the group not given the vaccine.
The Pfizer Covid-19 vaccine appears to offer 100% protection against the South African variant and most likely protects against the Brazilian variant, two new studies suggest.
Research published by Pfizer/BioNTech on Thursday offers the first in-human evidence of how the vaccine protects against the South African variant that has been worrying scientists.
The pharmaceutical giant said its findings show the vaccine is 100% effective in preventing Covid-19 cases in South Africa – where the South African variant is now common.
(PA Graphics)
Among 800 people in South Africa, nine cases of the South African variant of Covid were observed – all in the group not given the vaccine.